NCT05323591Completed
Prospective Observational Study of Filgotinib in Participants With Rheumatoid Arthritis in France
A Prospective, Non-interventional Study in Patients With Moderate to Severe Active Rheumatoid Arthritis in France Receiving Filgotinib for 2 Years
Source: ClinicalTrials.gov · Last updated 22 May 2026
Brief summary (registry, in English)
An observational study to describe the effectiveness, safety, and patient-reported outcomes (PROs) in participants with moderate to severe active rheumatoid arthritis (RA) in France receiving filgotinib in real-world setting.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 155 (actual)
- First submitted
- 5 Apr 2022
- Start date
- May 2022
- Primary completion date
- Mar 2026
- Lead sponsor
- Alfasigma S.p.A.
- Diseases
- Rheumatoid arthritis
- NCT number
- NCT05323591
What you commit to
- Study type: Observational
- Participants enrolled: 155
- From May 2022 to the primary completion date, Mar 2026
- 17 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Participation in any interventional or non-interventional study without prior approval from the Medical Lead. This does not preclude inclusion of participants enrolled to national registries.
Other
- Female participant is pregnant or intending to become pregnant while taking filgotinib.
Who the study is looking for
- Participants aged ≥18 years with a diagnosis of moderate to severe active RA being prescribed filgotinib in accordance with the local treatment practices and product label for the first time.
- Female participants of childbearing potential must agree to use contraception while taking filgotinib as per product label.
- Participants must be willing and able to use an electronic device to complete the study PROs.
- Participant must sign and date the Informed Consent Form (ICF) before enrollment into the study.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (17)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| CHU de Amiens Picardie Coordinator of this site? Confirm its status | Amiens | France | Unknown status |
| CHU Amiens Picardie site Nord Coordinator of this site? Confirm its status | Amiens | France | Unknown status |
| Hôpital Avicenne - AP-HP Coordinator of this site? Confirm its status | Bobigny | France | Unknown status |
| CHU Bordeaux Coordinator of this site? Confirm its status | Bordeaux | France | Unknown status |
| CH de Cahors Coordinator of this site? Confirm its status | Cahors | France | Unknown status |
| Clinique De L'infirmerie Protestante De Lyon Coordinator of this site? Confirm its status | Caluire-et-Cuire | France | Unknown status |
| Hopital Sud Francilien Corbeil Essonne Coordinator of this site? Confirm its status | Corbeil-Essonnes | France | Unknown status |
| Hopital Roger Salengro Coordinator of this site? Confirm its status | Lille | France | Unknown status |
| CHU de Nice Coordinator of this site? Confirm its status | Nice | France | Unknown status |
| Centre Hospitalier Regional d Orleans Coordinator of this site? Confirm its status | Orléans | France | Unknown status |
| Hopital Cochin Service A Coordinator of this site? Confirm its status | Paris | France | Unknown status |
| Hôpital Saint-Antoine Coordinator of this site? Confirm its status | Paris | France | Unknown status |
| Hopital Robert Debré Coordinator of this site? Confirm its status | Reims | France | Unknown status |
| CHU de Rouen Coordinator of this site? Confirm its status | Rouen | France | Unknown status |
| Centre Hospitalier Universitaire de Saint Etienne Coordinator of this site? Confirm its status | Saint-Etienne | France | Unknown status |
| CHU Toulouse Coordinator of this site? Confirm its status | Toulouse | France | Unknown status |
| CHRU de Tours Coordinator of this site? Confirm its status | Tours | France | Unknown status |
Related publications
This page is information, not medical advice. Discuss any trial with your doctor.